257 results

Merck hopes to boost its offering of specialty chemicals to the electronics industry with new purchase. Photograph: Emile Wamsteker/Bloomberg

Merck has agreed to buy AZ Electronic Materials for about £1.6 billion in cash to boost its offering of specialty chemicals to the electronics industr(...)

Drugmaker Novartis has yet to invite bids. Photograph: Alan Betson

Novartis’s animal-health business is drawing interest from drugmakers including Eli Lilly and Merck as the Swiss pharmaceutical giant prepares to sell(...)

Workers leaving the MSD plant in Swords, Co Dublin, after the announcement of 570 job losses. Photograph: Brenda Fitzsimons/The Irish Times

MSD’s troubles are fairly well known: a misfiring pipeline and continuing pressure to rationalise an organisation bloated by the merger of two majo(...)

Merck Sharpe & Dohme  cholesterol-lowering drug, Vytorin, emerges from a tablet press. Photographer: Jonathan Drake/Bloomberg News

Up to 570 staff at global pharma giant MSD face redundancy in the second major jobs blow at the company this year. MSD (formerly Merck Sharp & Doh(...)

Stand well back. You can feel the heat emanating from How to Survive a Plague. David France’s fiery, Oscar-nominated chronicle of the earliest years o(...)

  Many of Roche’s most promising medicines, such as rheumatoid arthritis treatment RoActemra and new breast cancer drugs Kadcyla and Perjeta are biologics, which unlike chemical drugs are proteins or cells derived from living organisms  that  are  hard to replicate. Photograph: Keystone, Gaetan Bally

Swiss drugmaker Roche is to invest 800 million Swiss francs ($880) in its global manufacturing facilities over the next five years, creating 500 jobs,(...)

A worker  outside a Merck facility in  New Jersey, US, yesterday.  The  drugmaker  will eliminate  8,500 of its 81,000 global workforce  in its latest revamp. Photograph: Emile Wamsteker/Bloomberg

Merck, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, has said it plans to cut annual operating costs by(...)

‘What we are doing in the universities is to support those people in developing solutions to challenges which are coming down the line,’ says Prof Kieran Hodnett

When most of us think about medicines, it is the finished products that come to mind: the shiny tablets or capsules that come in jars and packets. We(...)

Back in the dotcom boom, when investing in any and every technology start-up seemed to be the road to fast wealth, many large corporations jumped into(...)

Amgen employs about 250 people in Dublin in two sites in Dun Laoghaire andSantry.

US pharmaceutical group Amgen is to acquire Onyx Pharmaceuticals in a $10.4 billion (€7.8bn) deal that gives Amgen access to a rapidly expanding cance(...)

  • « First
  • Prev
  • 22
  • 23
  • 24
  • 25
  • 26
  • Next
  • Last »